Search…

Tianmu Pharmaceutical Company (600671.SH) subsidiary received the notice of drug re-registration approval.

22/09/2025

Wisdom Finance News APP learned that Tianmu Pharmaceutical Industry (600671.SH) has issued an announcement. The company's wholly-owned subsidiary, Huangshan Tianmu Pharmaceutical Industry Co., Ltd. (referred to as "Huangshan Tianmu"), recently received several "Drug Re-registration Approval Notices" including Liuwei Dihuang Pills issued by the Anhui Provincial Drug Administration.

Latest

2 m ago

Party group of the Ministry of Finance of the CPC: Promote regular and effective rectification of inspections and continue to do well in the "second half" of inspections.

2 m ago

The Communist Party Group of the Ministry of Finance: prudently promote the reform of the fiscal and taxation system, and improve the level of scientific management of finance.

3 m ago

CSRC: Deepen reforms of the Sci-Tech Innovation Board, Growth Enterprise Market, and Beijing Stock Exchange, improve the system and mechanisms for issuance and listing, and nurture and strengthen patient capital.

3 m ago

Foreign Exchange Administration Party Group: Maintain the basic stability of the renminbi exchange rate at a reasonable and balanced level and the basic balance of international payments.

3 m ago

Aviation Industry Corporation of China (AVIC): Controlling shareholder plans to reduce stake by 2.82% in the next 3 months.

See all latest